KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Receivables - Other (2016 - 2025)

Historic Receivables - Other for Eli Lilly (LLY) over the last 14 years, with Q4 2025 value amounting to $2.4 billion.

  • Eli Lilly's Receivables - Other rose 550.66% to $2.4 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.4 billion, marking a year-over-year increase of 550.66%. This contributed to the annual value of $2.4 billion for FY2025, which is 550.66% up from last year.
  • According to the latest figures from Q4 2025, Eli Lilly's Receivables - Other is $2.4 billion, which was up 550.66% from $3.3 billion recorded in Q3 2025.
  • Over the past 5 years, Eli Lilly's Receivables - Other peaked at $3.3 billion during Q3 2025, and registered a low of $1.1 billion during Q1 2021.
  • Its 5-year average for Receivables - Other is $1.9 billion, with a median of $1.7 billion in 2022.
  • Its Receivables - Other has fluctuated over the past 5 years, first plummeted by 2002.09% in 2024, then surged by 9066.54% in 2025.
  • Eli Lilly's Receivables - Other (Quarter) stood at $1.5 billion in 2021, then increased by 14.34% to $1.7 billion in 2022, then surged by 35.05% to $2.2 billion in 2023, then increased by 1.08% to $2.3 billion in 2024, then grew by 5.51% to $2.4 billion in 2025.
  • Its Receivables - Other was $2.4 billion in Q4 2025, compared to $3.3 billion in Q3 2025 and $3.0 billion in Q2 2025.